Skip to main content
Log in

Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy

  • Special Case
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

In order to take advantage of the metabolic information provided by positron emission tomography (PET) in cases of brain tumour, we have developed a technique to integrate PET images routinely in the planning of stereotactic brain biopsy. We used stereotactic PET with [18F]-labelled fluorodeoxyglucose (PET-FDG) in 38 patients undergoing brain biopsy. To evaluate the contribution of PET-FDG in guiding brain biopsy, we analyzed the diagnosis provided by the 78 Stereotactic trajectories obtained in these patients.

We found that stereotactic PET-FDG seemed to provide more information in cases of anaplastic astrocytomas and glioblastomas than in low-grade gliomas. Our results also show that biopsy trajectories performed in areas where increased FDG uptake is found within the lesion boundaries always provide interpretable specimens; this was not the case for trajectories guided by CT only. Therefore, the routine integration PET-FDG in the planning of stereotactic brain biopsy may lead to a reduction in sampling. Recently, we also tested consecutive stereotactic PET with [11C]-labelled methionine (PET-Met) and PET-FDG. This technique allowed us to compare accurately the tumoural glucose metabolism and protein synthesis.

Our results suggest that stereotactic PET may increase the diagnostic yield of brain biopsy and may improve the understanding of PET in neuro-oncology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Davide Donner, Umberto Rozzanigo, … Franca Chierichetti

References

  1. Alavi J, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M (1988) Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62: 1074–1078

    PubMed  Google Scholar 

  2. Black PM (1991) Brain tumors (Second of two parts). N Engl J Med 324: 1555–1564

    PubMed  Google Scholar 

  3. Chandrasoma PT, Smith MM, Apuzzo MLJ (1989) Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery. 24: 160–165

    PubMed  Google Scholar 

  4. Choksey MS, Valentine A, Shawdon H, Freer CER, Lindsay KD (1989) Computed tomography in the diagnosis of malignant brain tumours: do all patients require biopsy? J Neurol Neurosurg Psychiatry 52: 821–825

    PubMed  Google Scholar 

  5. Coleman RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC (1991) Clinical application of PET for the evaluation of brain tumors. J Nucl Med 32: 616–622

    PubMed  Google Scholar 

  6. Di Chiro G (1986) Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 22: 360–371

    Google Scholar 

  7. Feiden W, Steude U, Bise K, Gündisch O (1991) Accuracy of stereotactic brain tumor biopsy: comparison of the histologic findings in biopsy cylinders and resected tumor tissue. Neurosurg Rev 14: 51–56

    PubMed  Google Scholar 

  8. Glantz MJ, Burger PC, Herndon II JE, Friedman AH, Cairncross JG, Vick NA, Schold Jr SC (1991) Influence of the type of surgery on the histological diagnosis in patients with anaplastic gliomas. Neurology 41: 1741–1744

    PubMed  Google Scholar 

  9. Glantz MJ, Hoffman JM, Coleman RE, Friedman AH, Hanson MW, Burger PC, Herndon II JE, Meisler WJ, Schold Jr SC (1991) Identification of early recurrence of primary central nervous system tumors by [18]fluorodeoxyglucose positron emission tomography. Ann Neurol 29: 347–355

    PubMed  Google Scholar 

  10. Goldman S, Levivier M, Bouquey D, Bidaut LM, Pirotte B, Brucher J-M, Luxen A, Stanus E, Brotchi J, Hildebrand J (1993) Correlation of glucose metabolism and histopathology of gliomas using PET-guided stereotactic biopsy. Neurology 43: A249

    Google Scholar 

  11. Levivier M, Goldman S, Bidaut LM, Luxen A, Stanus E, Przedborski S, Balériaux D, Hildebrand J, Brotchi J (1992) Positron emission tomography-guided stereotactic brain biopsy. Neurosurgery 31: 792–797

    PubMed  Google Scholar 

  12. Mosskin M, von Holst H, Bergström M, Collins VP, Eriksson L, Johnström P, Norén G (1987) Positron emission tomography with 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies. Acta Radiol 28: 673–681

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pirotte, B., Goldman, S., Bidaut, L.M. et al. Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy. Acta neurochir 134, 79–82 (1995). https://doi.org/10.1007/BF01428509

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01428509

Keywords

Navigation